What Valion Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 0 |
| Total trades | 2 | 12 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 4 | 389,596 |
| Disposed | 2 | 38,950 |
| Net activity | +2 | +350,646 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wolf Lisa G | COO & CFO | Sep 18 | Withheld — tax / exercise cost · F | −2 | $2.12 | −$4.24 | 27 |
| Wolf Lisa G | COO & CFO | Sep 18 | Exercise / conversion · M | +4 | — | — | 29 |
| Wolf Lisa G | Chief Financial Officer | Jun 18 | Exercise / conversion · M | +92 | — | — | 618 |
| Handley Michael K | Chief Executive Officer | May 18 | Exercise / conversion · M | +2,206 | — | — | 11,030 |
| Bolton Sheryle | Director | Apr 15 | Open-market buy · P | +10,000 | $1.04 | +$10.4K | 10,000 |
| Valauri Christina Rizopoulos | Director | Apr 01 | Open-market buy · P | +19,000 | $0.95 | +$18K | 19,000 |
| Wolf Lisa G | Chief Financial Officer | Mar 18 | Exercise / conversion · M | +92 | — | — | 526 |
| Handley Michael K | Chief Operating Officer | Feb 18 | Exercise / conversion · M | +8,824 | — | — | 8,824 |
| Wolf Lisa G | Chief Financial Officer | Dec 18 | Withheld — tax / exercise cost · F | −302 | $1.87 | −$565 | 434 |
| Wolf Lisa G | Chief Financial Officer | Dec 18 | Exercise / conversion · M | +736 | — | — | 736 |
| Ernst Jennifer | Chief Executive Officer | Dec 18 | Withheld — tax / exercise cost · F | −5,262 | $1.87 | −$9.84K | 32,691 |
| Ernst Jennifer | Chief Executive Officer | Dec 18 | Exercise / conversion · M | +14,706 | — | — | 37,953 |
| Ernst Jennifer | Chief Executive Officer | Sep 22 | Grant / award · A | +22,541 | — | — | 23,247 |
| Bambach Kimberly Ann | Interim CFO | Mar 12 | Grant / award · A | +7,500 | — | — | 7,500 |
| Drexler Karen | Director | May 16 | Other Transaction · J | −15,111 | — | — | 18,076 |
| Ernst Jennifer | Chief Executive Officer | Nov 12 | Derivative Conversion · C | +26,986 | — | — | 1,199,877 |
| Ernst Jennifer | Chief Executive Officer | Nov 12 | Derivative Conversion · C | +1,391 | — | — | 1,172,891 |
Loading...
